A significant dilemma in the treatment of heart failure patients with sacubitril/valsartan or sodium-glucose co-transporter 2 inhibitors: Whether to add mineralocorticoid receptor antagonists.

Dimitrios Patoulias Christodoulos Papadopoulos Konstantinos Stavropoulos Konstantinos Imprialos Aristi Boulmpou Michael Doumas

Rev Port Cardiol

Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital "Hippokration", Greece; Veterans Affairs Medical Center, George Washington University, Washington, District of Columbia, United States.

Published: August 2022

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.repc.2021.10.009	DOI Listing

Publication Analysis

Top Keywords

dilemma treatment

treatment heart

heart failure

failure patients

patients sacubitril/valsartan

sacubitril/valsartan sodium-glucose

sodium-glucose co-transporter

co-transporter inhibitors

inhibitors add

add mineralocorticoid

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!